Bioinformatics analysis reveals the potential target of rosiglitazone as an antiangiogenic agent for breast cancer therapy
Background: Several studies have demonstrated the antitumor activity of rosiglitazone (RGZ) in cancer cells, includ- ing breast cancer cells. However, the molecular targets of RGZ in the inhibition of angiogenesis in breast cancer cells remain unclear. This study aimed to explore the potential tar...
محفوظ في:
| المؤلفون الرئيسيون: | , |
|---|---|
| التنسيق: | مقال PeerReviewed |
| اللغة: | English |
| منشور في: |
Springer
2022
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://repository.ugm.ac.id/278720/1/Hermawan_FA.pdf https://repository.ugm.ac.id/278720/ https://bmcgenomdata.biomedcentral.com/articles/10.1186/s12863-022-01086-2 https://doi.org/10.1186/s12863-022-01086-2 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|